Maria
Lv4
460 积分
2023-12-07 加入
-
SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension
21天前
已完结
-
Pulmonary Arterial Hypertension
23天前
已完结
-
Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial
2个月前
已完结
-
Safety of FEIBA and emicizumab (SAFE): Dose escalation study evaluating the safety of in vivo administration of activated prothrombin complex concentrate in haemophilia A patients on emicizumab
2个月前
已完结
-
FRONTIER1: a partially randomized phase 2 study assessing the safety, PK, and PD of Mim8, a factor VIIIa mimetic
3个月前
已完结
-
FRONTIER1: a partially randomized phase 2 study assessing the safety, PK, and PD of Mim8, a factor VIIIa mimetic
3个月前
已完结
-
A next generation FVIII mimetic bispecific antibody, Mim8, the impact on non‐factor VIII related haemostasis assays
3个月前
已完结
-
A novel chromogenic method for measuring factor VIII activity in the presence of the bispecific antibody emicizumab
3个月前
已关闭
-
The effect of a next generation factor VIII mimetic bispecific antibody (Mim8) on assays of factor VIII activity and thrombin generation
3个月前
已完结
-
Future treatments in hypertension: Can we meet the unmet needs of patients?
4个月前
已完结